Format

Send to

Choose Destination
J Clin Pharmacol. 2013 Feb;53(2):228-33. doi: 10.1177/0091270011436344.

Review of P-gp inhibition data in recently approved new drug applications: utility of the proposed [I(1) ]/IC(50) and [I(2) ]/IC(50) criteria in the P-gp decision tree.

Author information

1
US Food and Drug Administration, Silver Spring, Maryland 20993, USA.
PMID:
23436268
DOI:
10.1177/0091270011436344
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center